We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

115 hedge funds and large institutions have $184M invested in G1 Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 45 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more call options, than puts

Call options by funds: $1.24M | Put options by funds: $636K

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

6% more funds holding

Funds holding: 108 → 115 (+7)

32% less capital invested

Capital invested by funds: $270M → $184M (-$86.2M)

40% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 45

Holders
115
Holders Change
+7
Holders Change %
+6.48%
% of All Funds
1.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
27
Reduced
45
Closed
11
Calls
$1.24M
Puts
$636K
Net Calls
+$603K
Net Calls Change
+$663K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.58M
2
CA
CHI Advisors
New York
+$2.45M
3
HF
HRT Financial
New York
+$1.94M
4
PCM
Pinz Capital Management
New York
+$1.77M
5
RJA
Raymond James & Associates
Florida
+$1.58M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$6.25M
2
State Street
State Street
Massachusetts
-$5.93M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$5.89M
4
LOAMS
Lombard Odier Asset Management (Switzerland)
Switzerland
-$4.82M
5
N
Nuveen
North Carolina
-$4.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nisa Investment Advisors
101
Nisa Investment Advisors
Missouri
$16K +$13.3K +1,400 +206%
CAPTRUST Financial Advisors
102
CAPTRUST Financial Advisors
North Carolina
$15K – – –
Carson Wealth (CWM LLC)
103
Carson Wealth (CWM LLC)
Nebraska
$11K – – –
PGAM
104
Princeton Global Asset Management
New Jersey
$11K – – –
ACM
105
Aquatic Capital Management
Illinois
$11K +$13.3K +1,400 New
CG
106
Cutler Group
California
$8K – – –
HNWAG
107
High Net Worth Advisory Group
Florida
$8K – – –
AF
108
Allworth Financial
California
$6K -$4.86K -512 -41%
PFS
109
Prospera Financial Services
Texas
$5K +$5.69K +600 New
CFGS
110
Concourse Financial Group Securities
Alabama
$4K – – –
Barclays
111
Barclays
United Kingdom
$2K -$619K -65,289 -100%
Daiwa Securities Group
112
Daiwa Securities Group
Japan
$1K – – –
QC
113
Quent Capital
New York
$1K +$816 +86 New
Macquarie Group
114
Macquarie Group
Australia
$6 – – –
JAM
115
Jupiter Asset Management
United Kingdom
– -$527K -50,394 Closed
Voloridge Investment Management
116
Voloridge Investment Management
Florida
– -$346K -33,859 Closed
TD Asset Management
117
TD Asset Management
Ontario, Canada
– -$208K -20,418 Closed
JF
118
Jump Financial
Illinois
– -$198K -19,400 Closed
Cambridge Investment Research Advisors
119
Cambridge Investment Research Advisors
Iowa
– -$129K -12,667 Closed
Simplex Trading
120
Simplex Trading
Illinois
– -$35.2K -3,716 Closed
National Bank of Canada
121
National Bank of Canada
Quebec, Canada
– -$10K -1,000 Closed
US Bancorp
122
US Bancorp
Minnesota
– -$8K -772 Closed
DFCM
123
Dark Forest Capital Management
Puerto Rico
– -$5K -479 Closed
TWA
124
TCI Wealth Advisors
Arizona
– -$4K -388 Closed
QT
125
Quantbot Technologies
New York
– -$3K -376 Closed
1 2 3 4
5

GTHX Hedge Fund Activity: Q1 2022 in Review

115 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q1 2022, worth a combined $184M — down 32% from $270M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new GTHX positions and 11 closed out — a net gain of 7 holders — while 27 added to existing stakes and 45 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $3.58M. The largest seller was T. Rowe Price Associates, cutting an estimated $6.25M.

  • 115 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q1 2022, up from 108 in Q4 2021.
  • Funds reported $184M of G1 Therapeutics, Inc. Common Stock stock for Q1 2022, down 32% quarter-over-quarter.
  • 18 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q1 2022 and 11 closed out, a net change of +7 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q1 2022 was Fidelity Investments, an estimated $3.58M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q1 2022 was T. Rowe Price Associates, an estimated $6.25M sold.

Based on aggregated 13F filings for Q1 2022.